Ruffer LLP Exelixis, Inc. Transaction History
Ruffer LLP
- $1.93 Billion
- Q2 2025
A detailed history of Ruffer LLP transactions in Exelixis, Inc. stock. As of the latest transaction made, Ruffer LLP holds 76,310 shares of EXEL stock, worth $3.42 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
76,310
Previous 120,204
36.52%
Holding current value
$3.42 Million
Previous $4.44 Million
24.21%
% of portfolio
0.17%
Previous 0.17%
Shares
3 transactions
Others Institutions Holding EXEL
# of Institutions
639Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.5 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.28 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$1.01 Billion4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$664 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$528 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $14.4B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...